Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 4.54
-14.3 %
$ 2.35 M
Market Cap
0.0
P/E
INCOME STATEMENT
0
REVENUE
-10.5 M
OPERATING INCOME
-10.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
ENDRA Life Sciences Inc.
| Revenue | 0 |
| Cost Of Revenue | 275 K |
| Gross Profit | -275 K |
| Operating Expenses | 10.5 M |
| Operating Income | -10.5 M |
| Other Expenses | -460 K |
| Net Income | -10.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 6.17 K | 0.4 | 0.5 | 1.4 | 0.6 |
| GROSS PROFIT | ||||||||||
| Cost Of Revenue | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0 | 0.2 | 0.2 | 0.7 | 0.3 |
| Gross Profit | (0.3) | (0.2) | (0.2) | (0.2) | (0.1) | 6.17 K | 0.2 | 0.3 | 0.7 | 0.3 |
| OPERATING INCOME | ||||||||||
| Operating Expenses | 10.5 | 13.2 | 11.5 | 11.5 | 10.8 | 8.7 | 4.8 | 2.1 | 2.3 | 1.8 |
| Selling, General and Administrative Expenses | 5.5 | 6.6 | 6.0 | 5.6 | 4.3 | 4.0 | 2.9 | 1.6 | 1.3 | 1.0 |
| Research and Development Expenses | 5.0 | 6.6 | 5.5 | 5.9 | 6.6 | 4.7 | 1.9 | 0.5 | 1.0 | 0.9 |
| Operating Income | (10.5) | (13.2) | (11.5) | (11.5) | (10.8) | (9.0) | (4.6) | (1.8) | (1.6) | (1.5) |
| PRE-TAX INCOME | ||||||||||
| Interest Income Expense | 0 | 21.5 K | 0 | 0.2 | 2.4 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 0.5 | 21.5 K | 0.3 | (0.2) | (2.5) | (0.8) | (0.8) | (1.0) | (0.7) | (0.7) |
| Pre-Tax Income | (10.1) | (13.2) | (11.2) | (11.7) | (13.3) | (9.8) | (5.4) | (2.8) | (2.3) | (2.2) |
| NET INCOME | ||||||||||
| Tax Provision | 0 | 21.5 K | 41.5 K | 0.2 | 2.2 | (0.8) | 0.8 | 1.0 | 0.7 | 0.7 |
| Net Income | (10.1) | (13.2) | (11.2) | (12.0) | (15.6) | (9.8) | (5.4) | (2.8) | (2.3) | (2.2) |
| EPS | 1.11 | 4.57 | 5.47 | 12.5 | 41.5 | 43.5 | 39 | 14.2 | 11.7 | 11.2 |